DNM1

Dynamin-1 · Q05193 · DNM1 on Sugi Atlas →

174,399 patent compounds predicted against DNM1, 97,613 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL33718 SCHEMBL33718 0.79 14/20
Mecetronium Mecetronium (SCHEMBL60918) 1.00 12/20
Bromide Bromide (SCHEMBL60951) 1.00 12/20
Bromide Bromide (SCHEMBL25636) 0.94 12/20
Bromide Bromide (SCHEMBL44209) 0.94 12/20
SCHEMBL33567 SCHEMBL33567 0.65 12/20
SCHEMBL37593 SCHEMBL37593 1.00 11/20
SCHEMBL37598 SCHEMBL37598 1.00 11/20
SCHEMBL37784 SCHEMBL37784 1.00 11/20
Mecetronium Mecetronium (SCHEMBL41715) 1.00 11/20
Didecyldimethylammonium Didecyldimethylammonium (SCHEMBL29931) 0.94 11/20
SCHEMBL30455 SCHEMBL30455 0.94 11/20
SCHEMBL30485 SCHEMBL30485 0.94 11/20
Didecyldimethylammonium Didecyldimethylammonium (SCHEMBL20265) 0.88 11/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL24409) 0.88 11/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL29090) 0.88 11/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL29653) 0.88 11/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL33353) 0.88 11/20
SCHEMBL24179 SCHEMBL24179 0.60 11/20
SCHEMBL27777 SCHEMBL27777 0.56 11/20

Clinical trials — most relevant to DNM1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve) PHASE3WITHDRAWN
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease PHASE3RECRUITING
Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) PHASE3COMPLETED
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
A Clinical Study to Evaluate the Safety of MF1, a New Treatment for Parkinson's Disease-related Disorders (MF1 Study) PHASE1RECRUITING
The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease. PHASE1COMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) EARLY_PHASE1COMPLETED
Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy nanRECRUITING
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Skeletal Muscle Regeneration in Survivors of Critical Illness: How to Prevent Satellite Cell Failure? nanRECRUITING
Effect of Dietary Nitrate on Immobilization-induced Changes in Skeletal Muscle in Young Healthy Men nanRECRUITING
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
The Natural History of Mitochondrial Diseases nanRECRUITING
A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular Powerhouse) Dysfunction nanCOMPLETED
Targeting Mitochondrial Fusion and Fission to Prevent Atherosclerosis: Getting the Balance Right nanUNKNOWN
Ultrastructural Characteristics of Mitochondria in Cardiomyocytes in Heart Failure nanRECRUITING
Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance nanCOMPLETED
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Genetic Variation in CLTCL1 and Whole-body Glucose Control nanCOMPLETED
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma nanRECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Mitochondrial Dysfunctions Driving Insulin Resistance nanCOMPLETED
Predisposition Genes in Monogenic Diabetes (DIAMONO) nanCOMPLETED
Diagnostic Odyssey Survey 2 nanCOMPLETED
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING
Nicotinamide Riboside and Mitochondrial Biogenesis nanCOMPLETED
Identification of New Biomarkers of Insulin Resistance nanACTIVE_NOT_RECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a DNM1 binder may also engage these)

ProteinNameSimilarity
Q08DF4 1.000 Q08DF4 →
DNM2 Dynamin-2 1.000 landscape →
P39053 1.000 P39053 →
Q08877 1.000 Q08877 →
P39054 1.000 P39054 →
P39052 1.000 P39052 →
Q9UQ16 1.000 Q9UQ16 →
P21575 1.000 P21575 →
Q8BZ98 1.000 Q8BZ98 →
P27619 1.000 P27619 →
A6H7I5 1.000 A6H7I5 →
P39055 0.997 P39055 →
P20591 0.993 P20591 →
P79135 0.993 P79135 →
Q5R5G3 0.993 Q5R5G3 →
P33237 0.992 P33237 →
Q800G5 0.992 Q800G5 →
Q28379 0.991 Q28379 →
Q9NZN3 0.991 Q9NZN3 →
Q86T65 0.991 Q86T65 →
Q9QXY6 0.991 Q9QXY6 →
Q9H1H9 0.991 Q9H1H9 →
O35303 0.991 O35303 →
Q94CF0 0.991 Q94CF0 →
Q9BDI7 0.991 Q9BDI7 →
Q7T2P0 0.990 Q7T2P0 →
Q5U752 0.990 Q5U752 →
B4NBB0 0.990 B4NBB0 →
Q9FNX5 0.990 Q9FNX5 →
Q9N0Y3 0.990 Q9N0Y3 →